IBN SINA Pharma has a price-to-earnings (P/E) ratio of 12.30 (TTM). This compares to an industry average of 20.17. What is IBN SINA Pharma’s price-to-sales ratio? The P/S ratio for IBN SINA Pharma is ...

Today’s Google Doodle celebrates what would have been the 1038th birthday of Ibn Sina. Ibn Sina, who was born in the year 980, is often described as one of the pre-modern world’s most influential ...

IBN SINA Pharmaceuticals has decided to set up a subsidiary company for its natural medicine section to comply with the legal requirements of the Directorate General of Drug Administration (DGDA), ...

The Ibn Sina Pharmaceutical is going to invest Tk 10 crore in its subsidiary the Ibn Sina API Industry Ltd as part of its capital investment in order to purchase capital machineries, the company said ...

Abu Ali Al Hussain Ibn Abdullah Ibn Sina, better known in prominent Western sources by his Latinised name, Avicenna, was a leading Persian physician who became one of the most famous and influential ...

Partnership Brings Free Tests to Underserved Communities Amidst Surge in Infections Ibn Sina Foundation was established in 2001 by a group of business and healthcare professionals. The Foundation's ...